Paid Clinical Trials Washington, D.C.

Discover 799 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 799

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Washington DC, Baltimore MD, Frederick MD, Norfolk VAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Flywheel ExerciseFlywheel Exercise for CKD

Recruiting

Sponsor:

Washington D.C. Veterans Affairs Medical Center

Location:

Washington DC

Code:

NCT03582982

Conditions

Chronic Kidney Disease stage3

Chronic Kidney Disease stage4

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Eccentric overload exercise

ALLO-316Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Recruiting

PHASE1

Sponsor:

Allogene Therapeutics

Location:

Washington DC, New York NY, New Haven CT, Detroit MIshow 6 more

Code:

NCT04696731

Conditions

Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ALLO-316

ALLO-647

Fludarabine

Cyclophosphamide

LasmiditanA 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Washington DC, Baltimore MD, Kingwood WV, Scottdale PAshow 73 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

Attentional-Control TrainingFeasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

Recruiting

Sponsor:

Children's National Research Institute

Location:

Washington DC

Code:

NCT05099874

Conditions

Sickle Cell Disease

Attention Deficit

Cognitive Deficit in Attention

Eligibility Criteria

Sex: All

Age: 8 - 16

Healthy Volunteers: Not accepted

Interventions

EndeavorRx

IbalizumabA Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting

Sponsor:

Theratechnologies

Location:

Washington DC, Baltimore MD, Hillsborough NJ, Newark NJshow 21 more

Code:

NCT05388474

Conditions

HIV Infections

Multi-Antiviral Resistance

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

No ibalizumab or Pre-ibalizumab treatment

On ibalizumab treatment

Talquetamab, Daratumumab, PomalidomideA Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Washington DC, Baltimore MD, Richmond VA, Charlottesville VAshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

Elacestrant, CombinationOpen-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Washington DC, Fairfax VA, Baltimore MD, Norfolk VAshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

TabelecleucelTabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy

Recruiting

PHASE3

Sponsor:

Atara Biotherapeutics

Location:

Washington DC, Baltimore MD, Philadelphia PA, Pittsburgh PAshow 29 more

Code:

NCT03394365

Conditions

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

Solid Organ Transplant Complications

Lymphoproliferative Disorders

Allogeneic Hematopoietic Cell Transplant

Stem Cell Transplant Complications

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

tabelecleucel

Observational StudyDevelopment of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Recruiting

Sponsor:

Children's National Research Institute

Location:

Washington DC

Code:

NCT04833465

Conditions

Juvenile Idiopathic Arthritis

Systemic Lupus Erythematosus

Fibromyalgia

Eligibility Criteria

Sex: All

Age: 5 - 21

Healthy Volunteers: Not accepted

Interventions

No Intervention

GEn-1124A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS)

Recruiting

PHASE2

Sponsor:

GEn1E Lifesciences

Location:

Washington, D.C. DC, New York NY, Cleveland OH, Saint Louis MOshow 4 more

Code:

NCT05795465

Conditions

Respiratory Distress Syndrome, Acute

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

GEn-1124

Placebo